000 06194nam a22003735i 4500
001 312115
003 MX-SnUAN
005 20160429160531.0
007 cr nn 008mamaa
008 150903s2012 ne | o |||| 0|eng d
020 _a9789400729575
_99789400729575
024 7 _a10.1007/9789400729575
_2doi
035 _avtls000367059
039 9 _a201509030653
_bVLOAD
_c201405070436
_dVLOAD
_y201402251601
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aRC261-271
100 1 _aHayat, M.A.
_eeditor.
_9352922
245 1 0 _aPediatric Cancer, Volume 2 :
_bTeratoid/Rhabdoid, Brain Tumors, and Glioma /
_cedited by M.A. Hayat.
264 1 _aDordrecht :
_bSpringer Netherlands,
_c2012.
300 _axxii, 332 páginas 57 ilustraciones, 20 ilustraciones en color.
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
490 0 _aPediatric Cancer, Diagnosis, Therapy, and Prognosis,
_x2211-7997 ;
_v2
500 _aSpringer eBooks
505 0 _aPart I Teratoid/Rhabdoid.-  1. Pediatric Atypical Teratoid/Rhabdoid Tumors (An Overview).-  2. Pediatric Atypical Teratoid/Rhabdoid Tumor .-  3. Pediatric Rhabdomyosarcoma: Role Of Cell Cycle Regulators Alteration.-  4. Pediatric Atypical Teratoid/Rhabdoid Tumors: Imaging With Ct And Mri.-  5. Pediatric Atypical Teratoid/Rhabdoid Tumor: Diagnosis Using Imaging Techniques And Histopathology.-  6. Pediatric Atypical Teratoid/Rhabdoid Tumors: Differential Diagnosis -- Part II Brain Tumors (General).-  7. Pediatric Brain Tumors (An Overview).-  8. Pediatric Cns Primitive Neuroectodermal Tumor: Role Of The Wnt Pathway.-  9.  Neuroblastic Tumors: Status And Role Of Her Family Receptors.-  10.  Children With Neurofibromatosis Type 1: Positron Emission Tomography.-  11. Metabolite Profile Differences In Childhood Brain Tumors: 1h Magic Angle Spinning Nmr Spectroscopy.-  12. Central Nervous System Imaging In Childhood Leukemia.-  13. Immunohistochemistry In The Differential Diagnosis Of Adult And Pediatric Brain Tumors.-  14. Children With Brain Tumors: Role Of The Neurosurgeon.-  15. Pediatric Intraventricular Brain Tumors: Endoscopic Neurosurgical Techniques.-  16. Neurosurgical Management Of Pediatric Brain Tumors.-  17. Pediatric Brain Tumor Biopsy Or Resection: Use Of Postoperative Nonnarcotic Analgesic Medication.-  18. Clinical Trials In Pediatric Brain Tumors; Radiotherapy.-  19. Epileptic Seizures And Supratentorial Brain Tumors In Children.-  20. Postoperative Pain In Children: Advantage Of Using Nonnarcotic Analgesic Regimen.-  21. Pediatric Brain Tumors: Application Of Stratification Criteria To Refine Patient Management.-  22. Pediatric Supratentorial Primitive Neuroectodermal Tumor: Treatment With Chemotherapy And Radiation.-  23. Pediatric Cancer Survivors: Neurocognitive Late Effects.-  24. Adult Survivors Of Pediatric Cancer: Risk Of Cardiovacular Disease -- Part III Gliomas.-  25. Pediatric Glioma: Role Of Platelet-Derived Growth Factor Receptor.-  26. An Overview Of Pediatric High-Grade Gliomas And Diffuse Intrinsic Pontine Gliomas.-  27. Pediatric Low-Grade Glioma: The Role Of Neurofibromatosis-1 In Guiding Therapy.-  28. Treatment Of Pediatric Optic-Hypothalamic Gliomas: Prognosis.-  29. Pediatric Low-Grade Gliomas: Advantage Of Using Lower Doses Of Cisplatin/Etoposide.-  30. Pediatric Paragangliomas: Role Of Germline Mutation In Succinate Dehydrogenase.    .
520 _aPediatric Cancer: Teratoid/Rhabdoid, Brain Tumors, and Glioma   ·                  Epilepsy prognosis and treatment ·                  Symptoms of tumors in children ·                  Diagnostic imaging technology   This second volume in the Pediatric Cancer series edited by Professor M.A. Hayat presents a general introduction to the principles of diagnosis and treatment of children with brain tumors.   *Cancer is the leading cause of death by disease among U.S. children between infancy and age 15. Approximately 11,210 new cases of pediatric cancer are expected to be diagnosed in children 0–14 years of age in 2011.   A complete resource for researchers in the symptoms of tumors in children, epilepsy prognosis and treatment and diagnostic imaging technology, this volume presents and discusses:   ·        Molecular characterization of solid tumors, ·        The role of molecular pathways providing putative targets for new therapies. ·        High resolution magic angle spinning NMR spectroscopy, to determine metabolic profiles for small pieces of intact tissue and whole cells in culture, ·        The differences between adult and pediatric brain tumors, ·        The role of tumor suppressor genes and oncogenes in the development and progression of human malignancies, ·        Various neuroradiological imaging modalities in children with leukemia,   This volume also examines in detail the results of clinical trials using radiotherapy in pediatric brain tumors, such as medulloblastoma, ependymoma, craniopharyngioma, low-grade glioma, high-grade glioma, brainstem glioma, and germ cell tumors.   Aimed at researchers and medical oncologists, Pediatric Cancer volume 2, will also be of interest to medical technicians, pharmaceutical companies and of course, medical libraries.   Professor M.A. Hayat is Distinguished Professor at the Department of Biology, Kean University NJ, USA.     *National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services http://www.cancer.gov/aboutnci/servingpeople/cancer-statistics/snapshots  
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9789400729568
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-94-007-2957-5
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c312115
_d312115